ArticleChemSusChem2026
3D-Printed Platforms for Enzyme Immobilisation Screening and Direct Translation into Continuous-Flow Biocatalysis.
Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The development of immobilised biocatalysts for continuous-flow processes is still largely based on laborious trial-and-error screening, and conditions optimised on conventional carriers are often not directly transferable to structured reactors. Here, we introduce a 3D-printed methodology that integrates high-throughput screening of enzyme immobilisation with implementation in a continuous-flow reactor using the same photopolymeric formulation. The surface of the printed objects was modified through imidazolium-based supported ionic liquid phases. Immobilisation conditions for an enzymatic solution with alcohol dehydrogenase (ADH-200) were rapidly evaluated in a 96-well format using a colorimetric assay that enables quantitative comparison of activity and loading across multiples of conditions in a parallel fashion. Methyl-imidazolium-modified supports showed markedly higher enzymatic activity and immobilisation efficiency than other imidazolium-based ionic liquids, and the best-performing formulation was directly applied to functionalise the 3D-printed honeycomb-structured reactor. The resulting heterogeneous biocatalyst catalysed the oxidation of 1-phenylethanol to acetophenone under continuous flow with high conversion at moderate residence times and sustained performance over several hundred hours on stream. This integrated 3D-printed platform facilitates the identification of effective immobilisation chemistries and their translation to robust flow reactors, providing a general strategy for the rapid development of immobilised biocatalysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.